ArticleProceedings of the National Academy of Sciences of the United States of America2020

Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas.

Laura Esteban-Burgos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.